Angiogenic factors in superimposed preeclampsia

A longitudinal study of women with chronic hypertension during pregnancy

Uma Perni, Cristina Sison, Vijay Sharma, Geri Helseth, Amret Hawfield, Manikkam Suthanthiran, Phyllis August

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Imbalances in circulating angiogenic factors contribute to the pathogenesis of preeclampsia. To characterize levels of angiogenic factors in pregnant women with chronic hypertension, we prospectively followed 109 women and measured soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor at 12, 20, 28, and 36 weeks' gestation and postpartum. Superimposed preeclampsia developed in 37 (34%) and was early onset (<34 weeks) in 9 and later onset (34 weeks) in 28. Circulating levels of sFlt1 and the ratio of sFlt1 to placental growth factor were higher before clinical diagnosis at 20 weeks' gestation in women who subsequently developed early onset preeclampsia between 28 and 34 weeks compared with levels in women who never developed preeclampsia (P=0.001) or who developed late-onset preeclampsia (P=0.001). Circulating levels of sFlt1, soluble endoglin, and the ratio of sFlt1:placental growth factor were also significantly higher, and placental growth factor levels were significantly lower at the time of clinical diagnosis of superimposed preeclampsia in women with either early or late-onset superimposed preeclampsia compared with levels at similar gestational ages in those with uncomplicated chronic hypertension. We conclude that alterations in angiogenic factors are detectable before and at the time of clinical diagnosis of early onset superimposed preeclampsia, whereas alterations were observed only at the time of diagnosis in women with late-onset superimposed preeclampsia. Longitudinal measurements of angiogenic factors may help anticipate early onset superimposed preeclampsia and facilitate diagnosis of superimposed preeclampsia in women with chronic hypertension.

Original languageEnglish
Pages (from-to)740-746
Number of pages7
JournalHypertension
Volume59
Issue number3
DOIs
Publication statusPublished - 1 Mar 2012
Externally publishedYes

Fingerprint

Angiogenesis Inducing Agents
Pre-Eclampsia
Longitudinal Studies
Hypertension
Pregnancy
Vascular Endothelial Growth Factor Receptor-1
Intercellular Signaling Peptides and Proteins
Postpartum Period
Gestational Age
Pregnant Women

Keywords

  • angiogenic factors
  • chronic hypertension in pregnancy
  • superimposed preeclampsia

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Angiogenic factors in superimposed preeclampsia : A longitudinal study of women with chronic hypertension during pregnancy. / Perni, Uma; Sison, Cristina; Sharma, Vijay; Helseth, Geri; Hawfield, Amret; Suthanthiran, Manikkam; August, Phyllis.

In: Hypertension, Vol. 59, No. 3, 01.03.2012, p. 740-746.

Research output: Contribution to journalArticle

Perni, Uma ; Sison, Cristina ; Sharma, Vijay ; Helseth, Geri ; Hawfield, Amret ; Suthanthiran, Manikkam ; August, Phyllis. / Angiogenic factors in superimposed preeclampsia : A longitudinal study of women with chronic hypertension during pregnancy. In: Hypertension. 2012 ; Vol. 59, No. 3. pp. 740-746.
@article{5cb9c591c4ff4335b5b903c03d97dc65,
title = "Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy",
abstract = "Imbalances in circulating angiogenic factors contribute to the pathogenesis of preeclampsia. To characterize levels of angiogenic factors in pregnant women with chronic hypertension, we prospectively followed 109 women and measured soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor at 12, 20, 28, and 36 weeks' gestation and postpartum. Superimposed preeclampsia developed in 37 (34{\%}) and was early onset (<34 weeks) in 9 and later onset (34 weeks) in 28. Circulating levels of sFlt1 and the ratio of sFlt1 to placental growth factor were higher before clinical diagnosis at 20 weeks' gestation in women who subsequently developed early onset preeclampsia between 28 and 34 weeks compared with levels in women who never developed preeclampsia (P=0.001) or who developed late-onset preeclampsia (P=0.001). Circulating levels of sFlt1, soluble endoglin, and the ratio of sFlt1:placental growth factor were also significantly higher, and placental growth factor levels were significantly lower at the time of clinical diagnosis of superimposed preeclampsia in women with either early or late-onset superimposed preeclampsia compared with levels at similar gestational ages in those with uncomplicated chronic hypertension. We conclude that alterations in angiogenic factors are detectable before and at the time of clinical diagnosis of early onset superimposed preeclampsia, whereas alterations were observed only at the time of diagnosis in women with late-onset superimposed preeclampsia. Longitudinal measurements of angiogenic factors may help anticipate early onset superimposed preeclampsia and facilitate diagnosis of superimposed preeclampsia in women with chronic hypertension.",
keywords = "angiogenic factors, chronic hypertension in pregnancy, superimposed preeclampsia",
author = "Uma Perni and Cristina Sison and Vijay Sharma and Geri Helseth and Amret Hawfield and Manikkam Suthanthiran and Phyllis August",
year = "2012",
month = "3",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.111.181735",
language = "English",
volume = "59",
pages = "740--746",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Angiogenic factors in superimposed preeclampsia

T2 - A longitudinal study of women with chronic hypertension during pregnancy

AU - Perni, Uma

AU - Sison, Cristina

AU - Sharma, Vijay

AU - Helseth, Geri

AU - Hawfield, Amret

AU - Suthanthiran, Manikkam

AU - August, Phyllis

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Imbalances in circulating angiogenic factors contribute to the pathogenesis of preeclampsia. To characterize levels of angiogenic factors in pregnant women with chronic hypertension, we prospectively followed 109 women and measured soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor at 12, 20, 28, and 36 weeks' gestation and postpartum. Superimposed preeclampsia developed in 37 (34%) and was early onset (<34 weeks) in 9 and later onset (34 weeks) in 28. Circulating levels of sFlt1 and the ratio of sFlt1 to placental growth factor were higher before clinical diagnosis at 20 weeks' gestation in women who subsequently developed early onset preeclampsia between 28 and 34 weeks compared with levels in women who never developed preeclampsia (P=0.001) or who developed late-onset preeclampsia (P=0.001). Circulating levels of sFlt1, soluble endoglin, and the ratio of sFlt1:placental growth factor were also significantly higher, and placental growth factor levels were significantly lower at the time of clinical diagnosis of superimposed preeclampsia in women with either early or late-onset superimposed preeclampsia compared with levels at similar gestational ages in those with uncomplicated chronic hypertension. We conclude that alterations in angiogenic factors are detectable before and at the time of clinical diagnosis of early onset superimposed preeclampsia, whereas alterations were observed only at the time of diagnosis in women with late-onset superimposed preeclampsia. Longitudinal measurements of angiogenic factors may help anticipate early onset superimposed preeclampsia and facilitate diagnosis of superimposed preeclampsia in women with chronic hypertension.

AB - Imbalances in circulating angiogenic factors contribute to the pathogenesis of preeclampsia. To characterize levels of angiogenic factors in pregnant women with chronic hypertension, we prospectively followed 109 women and measured soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor at 12, 20, 28, and 36 weeks' gestation and postpartum. Superimposed preeclampsia developed in 37 (34%) and was early onset (<34 weeks) in 9 and later onset (34 weeks) in 28. Circulating levels of sFlt1 and the ratio of sFlt1 to placental growth factor were higher before clinical diagnosis at 20 weeks' gestation in women who subsequently developed early onset preeclampsia between 28 and 34 weeks compared with levels in women who never developed preeclampsia (P=0.001) or who developed late-onset preeclampsia (P=0.001). Circulating levels of sFlt1, soluble endoglin, and the ratio of sFlt1:placental growth factor were also significantly higher, and placental growth factor levels were significantly lower at the time of clinical diagnosis of superimposed preeclampsia in women with either early or late-onset superimposed preeclampsia compared with levels at similar gestational ages in those with uncomplicated chronic hypertension. We conclude that alterations in angiogenic factors are detectable before and at the time of clinical diagnosis of early onset superimposed preeclampsia, whereas alterations were observed only at the time of diagnosis in women with late-onset superimposed preeclampsia. Longitudinal measurements of angiogenic factors may help anticipate early onset superimposed preeclampsia and facilitate diagnosis of superimposed preeclampsia in women with chronic hypertension.

KW - angiogenic factors

KW - chronic hypertension in pregnancy

KW - superimposed preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=84857634410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857634410&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.111.181735

DO - 10.1161/HYPERTENSIONAHA.111.181735

M3 - Article

VL - 59

SP - 740

EP - 746

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -